Home > Riviste > Minerva Gastroenterologica e Dietologica > Fascicoli precedenti > Articles online first > Minerva Gastroenterologica e Dietologica 2015 Oct 22



Per citare questo articolo


Rivista di Gastroenterologia, Nutrizione e Dietetica

Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index



Minerva Gastroenterologica e Dietologica 2015 Oct 22


lingua: Inglese

Miraqule-C and mild heart failure: an 8-week registry

Belcaro G., Dugall M., Hu S., Corsi M., Hosoi M., Luzzi R., Ippolito E., Feragalli B., Ledda A.

Irvine3 labs & PAP/PEA Screening Project and the International Irvine Network, Spoltore and San Valentino, Dept. Sc. Med. Or. Biotec, G. D’Annunzio University, Ch- Pe, Italy


The aim of this registry study was the evaluation of possible benefits of a supplement including CoenzymeQ10 and a grape seed combination (MiraQule C, Alchem) in stable, moderate, heart failure patients. Results: The mean age of the 18 supplemented patients was 60.1;2 years (the age of the 22 controls was 61.1;2.2). The two groups were comparable. There were no dropouts in the two groups. In the 8 weeks of the registry, all supplemented patients remained in the NYHA class while 7 out of 22 in controls increased the level of heart failure passing into Class III. Systolic- diastolic pressure, heart rate, respiratory rate were minimally (non significantly lowered) with the supplement without differences controls. Ultrasound-derived ejection fraction was increased by supplementation (median of 2.7%) in the CoQ10 group (p<0.05) while there were minimal, non- significant differences in controls. Walking distance on treadmill was also significantly increased with the supplement (p<0.05) and only marginally in controls. The microcirculation (laser Doppler parameters and transcutaneous PO2, PCO2) improved significantly in the MQ-C group (p<0.05) and only marginally in controls. Oxidative stress was significantly decreased (p<0.05) with the CoQ10 preparation while there were minimal. Non-significant changes were observed in in controls. Tolerability and compliance were optimal (with more than 95% of the capsules correctly used). In conclusion in this supplement registry Miraqule-C seem to help patients with moderate heart failure and should be considered for larger studies.

inizio pagina

Publication History

Per citare questo articolo

Belcaro G, Dugall M, Hu S, Corsi M, Hosoi M, Luzzi R, et al. Miraqule-C and mild heart failure: an 8-week registry. Minerva Gastroenterol Dietol 2015 Oct 22. 

Corresponding author e-mail